Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Mir

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Frontiers in Oncology|April 17, 2023
Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ("Oligometastatic") and M2 ("Polymetastatic") subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC)Margaret F Meagher, Maria C Mir, Andrea Minervini, et al.
World Journal of Urology|February 9, 2019
Robotic versus laparoscopic radical nephrectomy: a large multi-institutional analysis (ROSULA Collaborative Group)Uzoma A Anele, Michele Marchioni, Bo Yang, et al.
The Journal of Urology|February 16, 2023
Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional CohortPeter S Kirk, Yair Lotan, Homayoun Zargar, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 18, 2023
The effect of cisplatin-based neoadjuvant chemotherapy on the renal function of patients undergoing radical cystectomyMatthew D Ho, Anna J Black, Homayoun Zargar, et al.
Urologic Oncology|February 15, 2020
Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancerDavid D'Andrea, Peter C Black, Homayoun Zargar, et al.
World Journal of Urology|August 9, 2021
Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancerDavid D'Andrea, Peter C Black, Homayoun Zargar, et al.
World Journal of Urology|September 28, 2022
Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancerSarah M H Einerhand, Anna J Black, Homayoun Zargar, et al.
World Journal of Urology|June 9, 2018
Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomyN Vasdev, H Zargar, J P Noël, et al.
Urologic Oncology|November 3, 2019
The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomyAnna J Black, Homayoun Zargar, Kamran Zargar-Shoshtari, et al.
World Journal of Urology|April 3, 2019
Partial versus radical nephrectomy in very elderly patients: a propensity score analysis of surgical, functional and oncologic outcomes (RESURGE project)Maria C Mir, Nicola Pavan, Umberto Capitanio, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Frontiers in Oncology|April 17, 2023
Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ("Oligometastatic") and M2 ("Polymetastatic") subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC)Margaret F Meagher, Maria C Mir, Andrea Minervini, et al.
World Journal of Urology|February 9, 2019
Robotic versus laparoscopic radical nephrectomy: a large multi-institutional analysis (ROSULA Collaborative Group)Uzoma A Anele, Michele Marchioni, Bo Yang, et al.
The Journal of Urology|February 16, 2023
Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional CohortPeter S Kirk, Yair Lotan, Homayoun Zargar, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 18, 2023
The effect of cisplatin-based neoadjuvant chemotherapy on the renal function of patients undergoing radical cystectomyMatthew D Ho, Anna J Black, Homayoun Zargar, et al.
Urologic Oncology|February 15, 2020
Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancerDavid D'Andrea, Peter C Black, Homayoun Zargar, et al.
World Journal of Urology|August 9, 2021
Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancerDavid D'Andrea, Peter C Black, Homayoun Zargar, et al.
World Journal of Urology|September 28, 2022
Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancerSarah M H Einerhand, Anna J Black, Homayoun Zargar, et al.
World Journal of Urology|June 9, 2018
Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomyN Vasdev, H Zargar, J P Noël, et al.
Urologic Oncology|November 3, 2019
The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomyAnna J Black, Homayoun Zargar, Kamran Zargar-Shoshtari, et al.
World Journal of Urology|April 3, 2019
Partial versus radical nephrectomy in very elderly patients: a propensity score analysis of surgical, functional and oncologic outcomes (RESURGE project)Maria C Mir, Nicola Pavan, Umberto Capitanio, et al.
Pageof 8